It's time to break the ice on pharmacy benefit managers' "drink the Kool-Aid" rhetoric! Join Pharmacists United for Truth & Transparency as we host guests from across the healthcare industry to discuss pharmacy news, healthcare issues, & (of course) PBMs... over cocktails.
…
continue reading
Join Employers Health's Chief Strategy Officer, Mike Stull, for our podcast on all things HR and employee benefits related. We'll cover your most frequently asked human resource questions, benefits best practices, our unique employer-led group purchasing program for pharmacy benefits management and more. We want this to be your podcast, with content that is relevant to you and your organization. Therefore, we invite you to submit questions or topics of interest that you would like covered in ...
…
continue reading
Join the movement! The Basic Christian is a discussion of sharing the gospel to the ends of the earth as well as learning to love God and mankind.
…
continue reading
Subject matter experts on controlling the administrative costs of healthcare while improving health outcomes.
…
continue reading
An In-Depth, Candid Conversation with Pharmacy Business Leaders
…
continue reading
Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
…
continue reading
The Off Script podcast offers in-depth interviews and discussions with industry experts about hot-button topics in pharma, and goes behind the scenes of Pharma Manufacturing’s print and online coverage, which follows the industry’s biggest issues surrounding scale-up, technology innovations, regulations and more
…
continue reading
A podcast that covers all things related to cancer. Providing inspiration, education, benefit and so much more to anyone linked to cancer in any way, shape or form.
…
continue reading
American Healthcare Entrepreneurs and Execs you might want to know. Talking. Relentless Health Value is a weekly interview podcast hosted by Stacey Richter, a healthcare entrepreneur celebrating fifteen years in the business side of healthcare. This show is for leaders in pharma, devices, payers, providers, patient advocacy and healthcare business. It's for health industry innovators, entrepreneurs or wantrepreneurs or intrapreneurs. Relentless Healthcare Value is the show for you if you wan ...
…
continue reading
Serving as an ERISA fiduciary is not just an honor and a privilege; it is a profound responsibility intertwined with the essential qualities of stewardship, governance, and leadership. Eric Dyson, the Executive Director of 90 North Consulting, dedicates each week to engaging with individuals who are deeply committed to achieving excellence beyond the traditional fiduciary role. If you are a member of a retirement plan committee, a plan fiduciary, or an ERISA advisor genuinely dedicated to en ...
…
continue reading
Healthcare is Hard: A Podcast for Insiders views healthcare transformation through the lens of prominent leaders across the industry. Through intimate one-on-one discussions with executives, policy advisors, and other “insiders,” each episode dives deep into the pressing challenges that come with changing how we care for people. Hear the unique perspectives of these industry leaders to get a better understanding of what is happening today, the challenges across the healthcare ecosystem, and ...
…
continue reading
Measures of central tendency
…
continue reading
Independent pharmacies are the last line of defense between patients and a pharmacy system that is quickly becoming a monopoly. The Independent Pharmacy Alliance Podcast will explore why Americans pay the highest drug prices in the world, highlight the life-saving services independent pharmacies provide, and how Pharmacy Benefit Managers utilize anti-competitive business practices to increase drug prices. In each episode, we‘ll talk to a pharmacist or front-line worker fighting for patients ...
…
continue reading
NFP introduces the Insights from the Experts podcast series. Each episode will showcase timely perspective from members of the NFP community, delivering information, analysis and solutions that address our clients’ most significant challenges. You can find archived episodes of Innovation Conversations at https://soundcloud.com/user-939810789.
…
continue reading
Healthcare innovations that make a difference. On the show, Cristy Gupton, President of Custom Benefits Solutions, meets with other experts in the industry and talks over solutions to current obstacles. Today's problems with healthcare and how we change it for the better.
…
continue reading
JC Scott, President & CEO of the Pharmaceutical Care Management Association, discusses the latest trends, public policy developments, and political challenges impacting drug pricing and healthcare. You'll hear the nation's top thought leaders, policy experts, and political analysts on topics like how employers, unions, and others use Pharmacy Benefit Managers (PBMs) to drive value for their members in the face of growing healthcare costs. You'll also learn about advancements in gene therapy, ...
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Drug Fix: US FDA Device Director Retires, PBM Execs On Capitol Hill, Voucher Program Renewal Push
27:09
27:09
Play later
Play later
Lists
Like
Liked
27:09
Editors from the Pink Sheet and Medtech Insight discuss the retirement of Jeff Shuren (:35), PBM executives again appearing unscathed after another Capitol Hill appearance (10:12), and the growing push to ensure the FDA’s rare pediatric disease priority review voucher program is renewed (20:41).More On These Topics From The Pink SheetShuren Steps D…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Special FTC Episode LIVE with Matt Stoller
1:05:05
1:05:05
Play later
Play later
Lists
Like
Liked
1:05:05
Join our host Lord Dr Jeremy as he discusses PBM antitrust issues, and the newly released FTC 6b study interim report with experts Matt Stoller and Greg Reybold. Opening music by JuliusHBy Pharmacists United for Truth & Transparency
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Encore! EP397: The Minefield That Is a PBM Contract and Also Some Advice for EBCs Who Are Taking Money Under the Table, With Paul Holmes
34:15
34:15
Play later
Play later
Lists
Like
Liked
34:15
In this encore episode of 'Relentlessly Seeking Value,' host Stacey Richter revisits a critically important conversation with ERISA attorney Paul Holmes about the complexities and hidden pitfalls in Pharmacy Benefit Manager (PBM) contracts. Aimed at CFOs and employer plan sponsors, Holmes highlights how poorly reviewed PBM contracts can lead to com…
…
continue reading
About Dennis Fowler: As a partner and practice leader at The Baldwin Group, Dennis helps employers achieve their culture and goals through innovative and tailored benefit strategies. He has over 14 years of experience in the insurance and human capital ecosystem, and he is passionate about disrupting the expensive and unsustainable healthcare syste…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pfizer advances obesity pill, FDA rejects Novo insulin, FTC releases PBM report [The good, the bad, the ugly]
3:28
3:28
Play later
Play later
Lists
Like
Liked
3:28
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Pfizer advances once-daily obesity pill The bad — FDA rejects Novo Nordisk once-weekly insulin The ugly — FTC releases long-awaited report on PBMsBy Pharma Manufacturing
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Exciting Future of Heart Failure Management
10:09
10:09
Play later
Play later
Lists
Like
Liked
10:09
Join Victoria Bradley and Dr. Andrew Freeman as they discuss the latest advancements in heart failure treatment, from innovative therapies to the role of AI and personalized medicine. Discover how technology is revolutionizing patient care, ensuring patient safety, and improving outcomes.By Citeline
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Early Detection Key in COPD Management (Q&A with Brittany Little, NP)
5:13
5:13
Play later
Play later
Lists
Like
Liked
5:13
This Q&A session emphasizes early diagnosis of COPD for better lung function preservation and disease control. It explores COPD symptoms, diagnosis tools, treatment options, and the importance of lifestyle changes, especially smoking cessation.By Citeline
…
continue reading
![Artwork](/static/images/128pixel.png)
1
FF5 #20 - DOL Target Date Guidance - Series Preview
8:07
8:07
Play later
Play later
Lists
Like
Liked
8:07
As an introduction and preview to a series - in this episode of Friday Fiduciary Five, Eric Dyson talks about the Department of Labor's guidance on target date funds. He highlights eight key points from the guidance, including establishing a process for comparing and selecting target date funds. Connect with Eric Dyson: Website: https://90northllc.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
EP445: Can a Primary-Care-Only Practice Survive in 2024? With Tom X. Lee, MD
47:53
47:53
Play later
Play later
Lists
Like
Liked
47:53
In this healthcare podcast, I am talking with Tom X. Lee, MD, who has a long history in primary care. He founded One Medical and then also, most recently, Galileo. Dr. Lee also was a founder at Epocrates (tossing that in for context). For a full transcript of this episode, click here. If you enjoy this podcast, be sure to subscribe to the free week…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Bill Leitner: 457(b) Plans and Texas Public Plan Coalition
28:40
28:40
Play later
Play later
Lists
Like
Liked
28:40
Bill Leitner is the Vice President of ISC Group, an independent firm that has helped clients navigate the complexities of the financial world since 1987. ISC Group, Inc. is affiliated with and Securities offered through Institutional Securities Corporation (ISC), Member FINRA/SIPC. Bill is a registered representative of ISC. In this episode, Eric a…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Digital Health Roundup: Brain Talk; Medtronic’s Digital Tech Report OR; UK Guidance
17:15
17:15
Play later
Play later
Lists
Like
Liked
17:15
In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights AI discussions at the HLTH Europe conference and an interview with Motif Neurotech's CEO Jacob Robinson. Elizabeth Orr discusses DeepWell DTx's newly launched VR game for treating stress-related hypertension and anxiety. Natasha Barrow provides an overview of Digital M…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Genentech's oral weight loss drug shows promise; FDA denies accelerated approval for Agenus' cancer drug; Orexo's opioid overdose drug rejected again [The good, the bad, the ugly]
3:35
3:35
Play later
Play later
Lists
Like
Liked
3:35
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Genentech's oral weight loss drug shows promise The bad — FDA denies accelerated approval for Agenus' cancer drug The ugly — Orexo's opioid overdose drug rejected again…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Navigating Competitive Intelligence | Leon Henderson-MacLennan, MD InThought Research
46:21
46:21
Play later
Play later
Lists
Like
Liked
46:21
In this episode, Dr. Leon Henderson-MacLennan of InThought Research discusses strategies for navigating competitive intelligence in the pharmaceutical industry, offering insights into data analysis, market trends, and the importance of strategic planning. Learn how to stay ahead in a rapidly evolving market. https://inthought.com/ https://www.bizof…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Scrip's Five Must-Know Things - 22 July 2024
14:39
14:39
Play later
Play later
Lists
Like
Liked
14:39
Audio roundup of selected biopharma industry content from Scrip over the business week ended 19 July 2024. In this episode: J&J’s Spravato on track for blockbuster status; US uptake of Rezzdifra held up by payers; CNS drugs are surprisingly valuable; obesity rules large cap stocks; and Legend buyout rumors validate China biotech.https://scrip.citel…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Medtech Connect 16: AI For Cross Border Regulation
19:31
19:31
Play later
Play later
Lists
Like
Liked
19:31
In this episode, Medtech Insight senior reporter Hannah Daniel speaks to DJ Fang, chief operating officer and co-founder of Pure Global. Pure Global uses AI to help device manufacturers navigate global regulations, and we talk about clinical trials, how countries incentivize medtech innovation, and the Biden Administration’s tariffs on some Chinese…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Drug Fix Special: Why The US Approves Most New Drugs Before The EU
30:31
30:31
Play later
Play later
Lists
Like
Liked
30:31
Pink Sheet reporter and editors discuss the impact of a US and EU drug approvals analysis that found the US FDA still clears many novel products first, including most new cell and gene therapies and cancer treatments.More On This Topics From The Pink SheetPharma Looks To America First: US FDA Holds Overwhelming Lead Over EMA In Novel Approvals: htt…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
FF5 #19 - Revenue Share - The Devil is in the Details
8:15
8:15
Play later
Play later
Lists
Like
Liked
8:15
In this episode of Friday Fiduciary Five, Eric Dyson talks about the importance of understanding revenue share in ERISA plans, highlighting potential issues arising from a lack of understanding such as inadequate fee leveling due to exceptions and inequitable distribution of expenses. Connect with Eric Dyson: Website: https://90northllc.com/ Phone:…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Help or Harm? How CHAI is Mitigating the Risk of AI in Healthcare
54:30
54:30
Play later
Play later
Lists
Like
Liked
54:30
With great power comes great responsibility and in healthcare, those words may have never held more meaning than they do with the advent of artificial intelligence. AI most certainly has the power to transform healthcare, and those in the industry working to develop and use it have an immense responsibility to shape principles that ensure these tec…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
국내 AI 신약개발, 선진국과 격차 줄이려면? (Korean-language podcast)
3:34
3:34
Play later
Play later
Lists
Like
Liked
3:34
신테카바이오 조해경 사장은 Scrip과의 인터뷰에서 국내 AI 신약 개발 현황을 글로벌 흐름와 비교하고, 국내외 경쟁에서 살아남기 위해 국내업계가 해야 할 일에 대해 이야기했습니다.https://scrip.citeline.com/SC150336/Korea-Looks-To-Close-Gap-In-AI-Drug-Development-CapabilitiesBy Citeline
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Importance of Exploring Genetic Potential
8:29
8:29
Play later
Play later
Lists
Like
Liked
8:29
Discover the key considerations critical to the genetic analysis for advanced therapies, including qPCR and dPCR. Don’t miss expert insights from Chandler Walker, Product Manager of Digital PCR Instruments at Thermo Fisher Scientific and Janelle Hart, managing editor at Citeline.By Citeline
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Scrip's Five Must-Know Things - 16 July 2024
13:43
13:43
Play later
Play later
Lists
Like
Liked
13:43
Audio roundup of selected biopharma industry content from Scrip over the business week ended 12 July 2024. In this episode: Q1’s top 10 drugs; Pfizer’s R&D leadership succession; Lilly bolsters IBD pipeline; first half deal volume up but value down; and EU firms’ China sentiment plummets.https://scrip.citeline.com/SC150587/Quick-Listen-Scrips-Five-…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Statewide Shifts to Pharmacy Standard of Care | Kate Gainer, PharmD, CEO , Iowa Pharmacists Assoc.
47:53
47:53
Play later
Play later
Lists
Like
Liked
47:53
Join us as Kate Gainer, Executive Vice President and CEO of the Iowa Pharmacy Association, discusses the transformative shifts in pharmacy practice. Learn about statewide adoption of the new pharmacy standard of care, legislative advocacy, and the future of pharmacy. Don't miss this insightful conversation! https://www.iarx.org/ https://www.bizofph…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
EPR Consultant Urges Producers To Start Collecting Packaging Data
16:55
16:55
Play later
Play later
Lists
Like
Liked
16:55
In this episode, HBW chats with Michael Washburn, principal at Washburn Consulting, on how producers of single-use packaging subject to extended producer responsibility laws rolling out in Oregon, Colorado and California next year can tackle the tedious work of collecting data on packaging materials.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
FF5 #18 - Meeting Minutes - How Much is Enough?
8:11
8:11
Play later
Play later
Lists
Like
Liked
8:11
In this episode of Friday Fiduciary Five, Eric Dyson talks about why meeting minutes are important, and how appropriately detailed minutes make a big difference in demonstrating adherence to a fiduciary standard of care. Connect with Eric Dyson: Website: https://90northllc.com/ Phone: 940-248-4800 Email: contact@90northllc.com LinkedIn: https://www…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
EP444: Two State Healthcare Laws Often Don’t Go as Planned: CON and COPA, With Ann Kempski
35:19
35:19
Play later
Play later
Lists
Like
Liked
35:19
In Episode 444 of Relentless Health Value, Stacey Richter speaks with healthcare consultant Ann Kempski about two state healthcare laws with unintended consequences: the Certificate of Need (CON) and the Certificate of Public Advantage (COPA) laws. They delve into the original intentions behind these laws, the ways in which they have often failed, …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Improving Communication: The Relationship Between Biotech And Biopharma
20:26
20:26
Play later
Play later
Lists
Like
Liked
20:26
Improving Communication: The Relationship Between Biotech And Biopharma by CitelineBy Citeline
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Paul Sommerstad & Ty Parrish: Measuring Plan Success
29:52
29:52
Play later
Play later
Lists
Like
Liked
29:52
About Paul Sommerstad: Paul is a Partner in the firm’s Retirement Plan Services Group. He has more than fifteen years of experience in the retirement plan industry and specializes in helping organizations understand how plan design can dramatically improve their employees’ ability to successfully retire and how proper governance can limit personal …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
【3分で解説 世界のファーマ】第19回 FDA「密な面談」を企業に呼び掛け (Japanese-language podcast)
3:37
3:37
Play later
Play later
Lists
Like
Liked
3:37
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。今回取り上げた記事はこちら「US FDA’s Cell-Gene Therapy Office Head Wants Sponsors To Seek Out Meetings( 邦題意訳:米国FDAの細胞遺伝子治療室長「もっと面談を」企業に求める理由は)」 (英語版)https://pink.citeline.com/PS154749/US-FDAs-Cell-Gene-Therapy-Office-Head-Wants-Sponsors-To-Seek-Out-Meetings※全文の…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Lilly Alzheimer’s drug gets full approval, Rocket gene therapy rejected, Eisai, BMS end ADC partnership [The good, the bad, the ugly]
3:44
3:44
Play later
Play later
Lists
Like
Liked
3:44
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — FDA grants Eli Lilly Alzheimer’s drug full approval The bad — FDA rejects Rocket gene therapy The ugly — Eisai, BMS end ADC partnershipBy Pharma Manufacturing
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Move Fast, Break Things, and Solve Problems | Ezriel Green, Founder/CEO at EzriRx
57:21
57:21
Play later
Play later
Lists
Like
Liked
57:21
Ezriel Green, founder and CEO of EzriRx, discusses the innovative ways his company is transforming the pharmacy industry. EzriRx focuses on streamlining operations for pharmacies, saving them time and money by integrating technology that simplifies processes like purchasing and inventory management. Green highlights the importance of continually re…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Scrip's Five Must-Know Things - 8 July 2024
15:54
15:54
Play later
Play later
Lists
Like
Liked
15:54
Audio roundup of selected biopharma industry content from Scrip over the business week ended 5 July 2024. In this episode: US approval for Lilly’s Alzheimer's contender; the challenges and rewards of late-stage ADCs; Eisai regains control of ADC from BMS; RSV vaccine developers hit by declining expectations; and an interview with Amgen’s Ian Thomps…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Scrip M&A Podcast: A Midyear Review of Biopharma Dealmaking and Expectations of What's Ahead
48:19
48:19
Play later
Play later
Lists
Like
Liked
48:19
Scrip's Joseph Haas, Mandy Jackson and Kevin Grogan discuss the biopharma dealmaking environment as we reach the midpoint of 2024. Haas reviews dealmaking data from the first six months of the year and discusses what experts expect in the months ahead. Jackson and Grogan talk about the industry mood coming out of the annual BIO conference in June a…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Non-Invasive Solutions: Exploring The Role Of Breath Biopsies In Early Detection
25:51
25:51
Play later
Play later
Lists
Like
Liked
25:51
In this episode of the In Vivo podcast, Billy Boyle, CEO of Owlstone Medical, discusses how his company is developing several breath biopsy products for use by clinicians, biopharma companies and researchers.By Citeline
…
continue reading
![Artwork](/static/images/128pixel.png)
1
FF5 #17 - Placing Service Provider Fees at Risk
6:07
6:07
Play later
Play later
Lists
Like
Liked
6:07
In this episode of Friday Fiduciary Five, Eric Dyson talks about the importance of regularly reviewing service standards and negotiating fee concessions. He also talks about how a fiduciary should always evaluate service providers through regular surveys or assessments to ensure they are meeting their contractual obligations and delivering agreed-u…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Communication, Aggregate Data, and a Dry IPA July
1:06:41
1:06:41
Play later
Play later
Lists
Like
Liked
1:06:41
Join Lord Dr Jeremy and this month's cocktail crew as they discuss the importance of communication in advocacy, the newly released 3Axis report, and how PUTT is offering solutions to the PBM problem. Special Guests: pharmacy owners & PUTT Executive Board members Brandi Chane and Lauren Young Opening music by JuliusH Production & Editing by Shannon …
…
continue reading
![Artwork](/static/images/128pixel.png)
51
EP443: Let Us Never Pay the First Bill in Honor of Marshall Allen
36:17
36:17
Play later
Play later
Lists
Like
Liked
36:17
To read the full show notes with links mentioned, be sure to visit our episode page and consider signing up for our free weekly newsletter. Episode 443 of Relentless Health Value pays tribute to the late Marshall Allen, an investigative journalist dedicated to exposing injustices within the American healthcare system. Hosted by Stacey Richter, the …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
[Solutions Spotlight] Streamlining oral dose packaging design
31:57
31:57
Play later
Play later
Lists
Like
Liked
31:57
By integrating a Quality by Design (QbD) approach, developers can design robust packaging from the outset, drastically reducing development time and costs. Understanding how moisture affects a product is key, allowing developers to use industry-accepted and validated models to predict and address potential stability issues early in the design phase…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Beth Allen: DOL Investigators are People Too
31:14
31:14
Play later
Play later
Lists
Like
Liked
31:14
Beth Allen has made a career of advising employers and benefits professionals on the legal obligations imposed by federal and state benefits-related laws. She has a knack for taking complicated compliance concepts and effectively explaining them to plan sponsors, HR leaders, and company executives alike. In this episode, Eric and Beth Allen discuss…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
In Vivo Podcast Episode with Stefan Woxström
27:02
27:02
Play later
Play later
Lists
Like
Liked
27:02
In Vivo Podcast Episode with Stefan Woxström by CitelineBy Citeline
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 44 - Pharmacy Benefit Rebate Credit
25:06
25:06
Play later
Play later
Lists
Like
Liked
25:06
This episode features Employers Health Chief Operating Officer, Zach Hostetler. He joins our Chief Sales Officer, Mike Stull to discuss pharmacy benefit rebate credits and why they exist. They'll cover how rebate credits are calculated, how long we can expect rebate credits to be around, how Employers Health is working to validate the value of the …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Verona wins COPD nod, FDA rejects Merck-Daiichi ADC, Glenmark recalls potassium chloride capsules [The good, the bad, the ugly]
3:42
3:42
Play later
Play later
Lists
Like
Liked
3:42
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Verona wins FDA nod for COPD The bad — FDA issues CRL to Merck-Daiichi lung cancer ADC The ugly — Glenmark recalls 114 batches of potassium chloride capsules…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
How To Innovate For The Ages, With Bayer’s Reese Fitzpatrick And Rachel Koontz
47:55
47:55
Play later
Play later
Lists
Like
Liked
47:55
Aspirin is celebrating its 125th anniversary this year. To find out what brand owner Bayer Consumer Health is doing to celebrate this occasion, and what it is doing to take the brand into the next 125 years, HBW Insight chats with the company’s senior vice president, Global Head Allergy, Cough/Cold, Pain and Heart Health, Reese Fitzpatrick, and hea…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Mastering Time Management | State Senator Shane Reeves, PharmD., CEO Twelve Stone Health
55:45
55:45
Play later
Play later
Lists
Like
Liked
55:45
In this episode of The Business of Pharmacy Podcast™, Mike Koelzer interviews Senator Shane Reeves, Pharm.D., State Senator of TN and CEO of Twelve Stone Health Partners, about his expert strategies for mastering time management and boosting productivity. Shane shares practical tips from his extensive experience in both the pharmacy industry and po…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Scrip's Five Must-Know Things - 1 July 2024
16:53
16:53
Play later
Play later
Lists
Like
Liked
16:53
Audio roundup of selected biopharma industry content from Scrip over the business week ended 28 June 2024. In this episode: global CEO remuneration; another late-stage loss for Merck KgaA; deals shift to smaller M&A, partnering; Bayer’s Parkinson’s bets bear fruit; and India looks to innovate CAR-T models.https://scrip.citeline.com/SC150517/Quick-L…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Over the Counter: EPR Consultant Urges Producers To Start Collecting Packaging Data
16:55
16:55
Play later
Play later
Lists
Like
Liked
16:55
In this episode, HBW chats with Michael Washburn, principal at Washburn Consulting, on how producers of single-use packaging subject to extended producer responsibility laws rolling out in Oregon, Colorado and California next year can tackle the tedious work of collecting data on packaging materials.…
…
continue reading